Form 8-K aTYR PHARMA INC For: Jun 16

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Form 8-K aTYR PHARMA INC For: Jun 16

aTyr Pharma (LIFE) Reports Q1 Loss of $9.39/Share

June 18, 2015 4:25 PM EDT

aTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($9.39), versus ($7.87) reported last year.

The Company successfully completed its initial public offering following the end of the quarter on May 12, 2015, with estimated net proceeds of $76.9 million. Total cash and investments are expected to be approximately $145 million as of June 30, 2015.

Proceeds raised during the first half of 2015 will be used to fund operations, including the ongoing Phase 1b/2 clinical trial of Resolaris, a first-in-class protein therapeutic in adult patients... More